Pentoxifylline inhibits tumor necrosis factor-α-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells
- 30 September 1994
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 16 (9) , 723-736
- https://doi.org/10.1016/0192-0561(94)90092-2
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Studies on the acyl-chain selectivity of cellular phospholipases A2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific‐membrane phospholipidsJournal of Cellular Physiology, 1990
- Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortalityLife Sciences, 1989
- CALCIUM CONTENT OF THE ERYTHROCYTES: A SENSITIVE AND EASY HANDLING METHOD FOR MEASURING FREE CALCIUM IONS, AND MODULATION OF THE Ca2+ ION CONCENTRATION BY THE CALCIUM ANTAGONISTS NIFEDIPINE AND PENTOXIFYLLINEClinical and Experimental Pharmacology and Physiology, 1989
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989
- Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cellsFEBS Letters, 1988
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengersTrends in Neurosciences, 1988
- Downregulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase C activators.The Journal of Experimental Medicine, 1987
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987